Oberweis Asset Management’s Eli Lilly LLY Stock Holding History

Oberweis Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+183	New	+$187K	﹤0.01%	175
2023 Q3	–	Sell	-609	Closed	-$286K	–	203
2023 Q2	$286K	Hold	609	–	–	0.03%	172
2023 Q1	$209K	Sell	609 -30	-5%	-$10.1K	0.03%	168
2022 Q4	$234K	Sell	639 -29	-4%	-$10.3K	0.05%	159
2022 Q3	$216K	Hold	668	–	–	0.05%	165
2022 Q2	$217K	Buy	+668	New	+$201K	0.05%	151

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oberweis Asset Management's LLY Position: Q2 2026 in Review

Oberweis Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 183 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #175 among its holdings. This is a return to the name: Oberweis Asset Management previously reported a position in LLY as recently as Q2 2023.

Oberweis Asset Management first reported a position in LLY in Q2 2022 and has held it in 6 quarters since. The position peaked at $286K in Q2 2023. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Oberweis Asset Management held 183 shares of Eli Lilly worth $219K as of Q2 2026.
Eli Lilly was a new Oberweis Asset Management position in Q2 2026.
Eli Lilly made up ﹤0.01% of Oberweis Asset Management's portfolio in Q2 2026, its #175 holding.
Oberweis Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 6 quarters since.
Oberweis Asset Management's Eli Lilly position peaked at $286K in Q2 2023.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.